blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1611892

EP1611892 - Pharmaceutical compositions comprising drospirenone [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.07.2010
Database last updated on 13.09.2024
Most recent event   Tooltip16.07.2010No opposition filed within time limitpublished on 18.08.2010  [2010/33]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2007/19]
Former [2007/15]For all designated states
Bayer Schering Pharma AG
Müllerstrasse 178
13353 Berlin / DE
Former [2006/01]For all designated states
Schering Aktiengesellschaft
Müllerstrasse 178
13342 Berlin / DE
Inventor(s)01 / Heil, Wolfgang
Am Wassertum 24
21435 Stelle / DE
02 / Hilmann, Juergen
Ugandastrasse 9
13351 Berlin / DE
03 / Lipp, Ralph
11780 Auburn Creek Crossing
Zionsville, IN 46077 / US
04 / Schuermann, Rolf
Kantstrasse 83
D-14513 TELTOW / DE
 [2006/06]
Former [2006/01]01 / Heil, Wolfgang
Am Wassertum 24
21435 Stelle / DE
02 / Hilmann, Juergen
Ugandastrasse 9
13351 Berlin / DE
03 / Lipp, Ralph
11780 Auburn Creek Crossing
Zionsville, IN 46077 / US
04 / Schuermann, Rolf
Schottmüllerstrasse 54 D
14167 Berlin / DE
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[N/P]
Former [2008/31]Plougmann & Vingtoft A/S
Sundkrogsgade 9 P.O. Box 831
2100 Copenhagen Ø / DK
Former [2006/01]Plougmann & Vingtoft A/S
Sundkrogsgade 9, P.O. Box 831
2100 Copenhagen / DK
Application number, filing date05076969.418.01.2001
[2006/01]
Priority number, dateEP2000020018318.01.2000         Original published format: EP 00200183
US2000048402618.01.2000         Original published format: US 484026
[2006/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1611892
Date:04.01.2006
Language:EN
[2006/01]
Type: A3 Search report 
No.:EP1611892
Date:01.02.2006
[2006/05]
Type: B1 Patent specification 
No.:EP1611892
Date:09.09.2009
Language:EN
[2009/37]
Search report(s)(Supplementary) European search report - dispatched on:EP15.12.2005
ClassificationIPC:A61K31/585, A61P33/00
[2006/01]
CPC:
A61K31/565 (EP,KR); A61K31/585 (EP); A61K9/2018 (EP);
A61P15/00 (EP); A61P15/12 (EP); A61P17/00 (EP);
A61P17/14 (EP); A61P19/10 (EP); A61P25/00 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P33/00 (EP);
A61P5/00 (EP); A61P5/24 (EP); A61P5/30 (EP);
A61P9/00 (EP) (-)
C-Set:
A61K31/565, A61K2300/00 (EP);
A61K31/585, A61K2300/00 (EP);
A61K31/585, A61K31/565 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2006/01]
Extension statesLT26.08.2005
LV26.08.2005
RO26.08.2005
SI26.08.2005
TitleGerman:Pharmazeutische Zubereitung enthaltend Drospirenon[2006/01]
English:Pharmaceutical compositions comprising drospirenone[2006/01]
French:Compositions pharmaceutiques comprenant du drospirenone[2006/01]
Examination procedure26.08.2005Examination requested  [2006/01]
18.04.2006Despatch of a communication from the examining division (Time limit: M04)
05.07.2006Reply to a communication from the examining division
30.03.2009Communication of intention to grant the patent
27.07.2009Fee for grant paid
27.07.2009Fee for publishing/printing paid
Parent application(s)   TooltipEP01900579.2  / EP1257280
Opposition(s)10.06.2010No opposition filed within time limit [2010/33]
Fees paidRenewal fee
26.08.2005Renewal fee patent year 03
26.08.2005Renewal fee patent year 04
26.08.2005Renewal fee patent year 05
19.12.2005Renewal fee patent year 06
15.12.2006Renewal fee patent year 07
14.12.2007Renewal fee patent year 08
14.01.2009Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9827929  (SCHERING AG [DE], et al) [A] 1-26 * claims 2,11 *;
 [E]WO0115701  (SCHERING AG [DE], et al) [E] 1-26* the whole document *;
 [A]  - MUHN P ET AL, "DROSPIRENONE: A NOVEL PROGESTOGEN WITH ANTIMINERALOCORTICOID AND ANTIANDROGENIC ACTIVITY PHARMACOLOGICAL CHARACTERIZATION IN ANIMAL MODELS", CONTRACEPTION, GERON-X, INC., LOS ALTOS, CA, US, (199502), vol. 51, no. 2, ISSN 0010-7824, pages 99 - 110, XP000908817 [A] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1016/0010-7824(94)00015-O
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.